Last reviewed · How we verify
Ametriodic Acid (IODAMIDE)
At a glance
| Generic name | IODAMIDE |
|---|---|
| Sponsor | Bracco |
| Drug class | iodamide |
| Modality | Small molecule |
| Therapeutic area | Hematology |
| Phase | FDA-approved |
| First approval | 1978 |
Approved indications
- Aortography
- Arteriography of cerebral arteries
- Cholangiogram
- Computed tomography of entire head
- Digestive System Radiography
- Hysterosalpingogram
- Intraosseous venography
- Peripheral Arteriography
- Radiographic imaging procedure
- Renal arteriography
- Retrograde Cystourethrography
- Retrograde pyelogram
- Splenoportogram by splenic arteriography
- Venography: peripheral
Common side effects
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ametriodic Acid CI brief — competitive landscape report
- Ametriodic Acid updates RSS · CI watch RSS
- Bracco portfolio CI